(HealthDay)—For children with high-risk group 3 medulloblastoma, therapy intensification with carboplatin improves event-free survival, according to a study published online July 22 in JAMA Oncology. Sarah E. S. Leary, M.D., from Seattle Children’s, and colleagues examined therapy intensification with carboplatin…
Read MoreThe Best Ready-to-Drink Cold Brew Coffee for a Quick & Easy Boost
Need an energy boost but there’s no time to brew a cup of joe? Keep ready-to-drink cold brew coffee in your fridge for an easy pick-me-up. Related story Amazon's Fitbit & Apple Watch Alternative Is the Perfect Father's Day Gift…
Read More